Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Organigram GlobalSTU:0OG -3.36%63 3-1 Month Momentum % is -15.74% as of Aug. 15, 2026. GuruFocus rates STU:0OG with a GF Score™ of 63/100 and a GF Value™ of €1.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Organigram Global ranks worse than 77.34% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-15), Organigram Global's 3-1 Month Momentum % is -15.74%.
The industry rank for Organigram Global's 3-1 Month Momentum % or its related term are showing as below:
STU:0OG's 3-1 Month Momentum % is ranked worse than 77.34% of 1024
companies
in the Drug Manufacturers industry
Industry Median: -5.935
vs STU:0OG: -15.74
Organigram Global (STU:0OG) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Organigram Global 3-1 Month Momentum % Related Terms
STU:0OG vs ZTS: 3-1 Month Momentum % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organigram Global 3-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Organigram Global's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Organigram Global's 3-1 Month Momentum % falls into.
Organigram Global (STU:0OG) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organigram Global (STU:0OG) has a 3-1 Month Momentum % of -15.74% as of Aug. 15, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Organigram Global and its competitors. According to the industry distribution chart, Organigram Global ranks #792 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 77.3%.
Is Organigram Global's 3-1 Month Momentum % too high?
Organigram Global's current 3-1 Month Momentum % is -15.74%. Based on the distribution chart, Organigram Global ranks #792 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Organigram Global has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's 3-1 Month Momentum % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Organigram Global ranks #792 out of 1024 companies for 3-1 Month Momentum %. This places Organigram Global in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Drug Manufacturers company?
A good 3-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Organigram Global and its competitors. Organigram Global's current 3-1 Month Momentum % is -15.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.54, compared to a current price of €1.04 — trading 32.7% below its estimated fair value. The current 3-1 Month Momentum % is -15.74%. Organigram Global's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current 3-1 Month Momentum % is -15.74% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organigram Global (STU:0OG) Overvalued in 2026?
Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued.
The current stock price of €1.04 is trading 32.7% below its estimated GF Value™ of €1.54.
GuruFocus considers Organigram Global to be Possible Value Trap.
Key valuation signals for STU:0OG:
3-1 Month Momentum %: -15.74%
GF Value™: €1.54 vs. price of €1.04 (32.7% below fair value)
No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
63GF Score
Get the complete analysis for STU:0OG
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:0OG has been successfully added to your 
